Page 1 of 2 pages :  1 2 >

1. Feature Article: Hypomethylating Agent Induction Therapy Followed By Hematopoietic Cell Transplantation Is Feasible in Patients With Myelodysplastic Syndromes

H&O January 2010 Volume 8, Issue 1

Christopher R. Cogle, MD, Iman Imanirad, MD, Laura E. Wiggins, PharmD, Jack Hsu, MD, Randy Brown, MD, Juan C. Scornik, MD, and John R. Wingard, MD

Download PDF

2. Hem/Onc News: Recent Clinical Findings

H&O August 2009 Volume 7, Issue 8

Ellie Vershvovsky

Download PDF

3. Hem/Onc News: Recent Clinical Advances

H&O April 2009 Volume 7, Issue 4

Ellie Vershvovsky

Download PDF

4. Clinical Roundtable Monograph: Recent Advances in Low- and Intermediate-1–Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy

H&O December 2008 Volume 6, Issue 12 , 19

Richard Stone, MD, Mikkael Sekeres, MD, MS, Guillermo Garcia-Manero, MD, and Roger M. Lyons, MD, FACP

Download PDF

5. Clinical Update: Treating Low-risk Myelodysplastic Syndromes in the Community Setting

H&O June 2008 Volume 6, Issue 6

Larry D. Cripe, MD

Download PDF

6. Advances in LLM: Lenalidomide in Myelodysplastic Syndromes

H&O April 2008 Volume 6, Issue 4

Alan F. List, MD

Download PDF

7. Advances in LLM: Susceptibility to Therapy-related Myelodysplastic Syndromes and Acute Myeloid Leukemia

H&O March 2008 Volume 6, Issue 3

Heinz Sill, MD

Download PDF

8. Hem/Onc News: Recent Clinical Findings

H&O January 2008 Volume 6, Issue 1

Stuart Schrader

Download PDF

9. Supplement 10: Recent Advances in the Treatment of MDS

H&O July 2007 Volume 5, Issue 7

July 2007. Volume 5, Issue 7, Supplement 10.

Download PDF

10. Feature Article: Use of Hypomethylating Agents in Myelodysplastic Syndromes

H&O July 2007 Volume 5, Issue 7

Ehab Atallah, MD, and Guillermo Garcia-Manero, MD

Download PDF

Page 1 of 2 pages :  1 2 >